Encainide

Encainide
Systematic (IUPAC) name
	4-methoxy-N-[2-(1-methyl-2-piperidin-1-ylethyl)phenyl]benzamide
Clinical data
Trade names	Enkaid
AHFS/Drugs.com	Micromedex Detailed Consumer Information
MedlinePlus	a605040
Pregnancy cat.	?
Legal status	Withdrawn
Identifiers
CAS number	66778-36-7
ATC code	C01BC08
PubChem	CID 48041
DrugBank	APRD00613
ChemSpider	43697
UNII	SY3J0147NB
KEGG	D07894
ChEBI	CHEBI:4788
Chemical data
Formula	C22H28N2O2
Mol. mass	352.47 g/mol
SMILES	eMolecules & PubChem
	InChI InChI=1S/C22H28N2O2/c1-24-16-6-5-8-19(24)13-10-17-7-3-4-9-21(17)23-22(25)18-11-14-20(26-2)15-12-18/h3-4,7,9,11-12,14-15,19H,5-6,8,10,13,16H2,1-2H3,(H,23,25) ; Key:PJWPNDMDCLXCOM-UHFFFAOYSA-N ;
(what is this?) (verify);

From Wikipedia, the free encyclopedia

Jump to: navigation, search

Encainide (trade name Enkaid) is a class Ic antiarrhythmic agent. It is no longer used because its frequent proarrhythmic side effects.^[1]

[edit] See also

^ Echt, D. S.; Liebson, P. R.; Mitchell, L. B.; Peters, R. W.; Obias-Manno, D.; Barker, A. H.; Arensberg, D.; Baker, A. et al (1991). "Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo". New England Journal of Medicine 324 (12): 781–788. doi:10.1056/NEJM199103213241201. PMID 1900101. edit

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.